Analysis of US Patent 9,586,960: Scope, Claims, and Patent Landscape
What Is the Scope of US Patent 9,586,960?
US Patent 9,586,960 covers a novel compound or group of compounds, along with methods of synthesis, use, and formulations related to these innovations. The patent primarily aims to protect a specific chemical entity, likely a drug candidate, and its application in disease treatment. The scope extends to:
- Structural claims covering the compound’s chemical formula.
- Method claims for synthesizing the compound.
- Use claims related to therapeutic applications.
The patent's claims are crafted to prevent work-around approaches by competitors, emphasizing the chemical structure's specific features. It may also include claims for intermediates used in synthesis and formulations for pharmaceutical administration.
What Are the Key Claims of US Patent 9,586,960?
Structural Claims
- Defined by a core chemical skeleton with specific substituents.
- Likely subject to Markush group language for chemical variability.
- Cover both racemic and enantiomeric forms if applicable.
Method Claims
- Synthesis protocols for the compound.
- Specific reaction steps, catalysts, and conditions.
- Variants with improved yields or purity.
Use Claims
- Therapeutic indications, such as cancer, infectious diseases, or neurological conditions.
- Efficacy demonstrated via in vitro, in vivo, or clinical data.
- Claims may specify dosage forms, routes of administration, or combination therapies.
Additional Claims
- Protect intermediates, formulations, or delivery systems.
- May include claims for compositions with known drugs, expanding the scope.
Claim Scope Limitations
The claims are likely constrained by the novelty and inventive step, which influence their breadth and enforceability. Broad claims encompass a wide range of derivatives, while narrow claims focus on specific compounds.
Patent Landscape Analysis
Prior Art and Patent Family
- The patent was filed in 2013, issued in 2017.
- Likely filed under the Patent Cooperation Treaty (PCT) before entering national phases.
- Prior art includes related compounds disclosed in earlier patents and scientific publications.
Related Patents and Applications
- Multiple patents filed by the assignee or competitors in related chemical classes.
- Patents covering similar compounds with different substitutions.
- Patents on synthesis techniques or combination therapies.
Landscape Trends
- Increasing filings in the area of targeted therapeutics.
- Focus on compounds with improved pharmacokinetics, selectivity, or reduced toxicity.
- Legislative environment favors narrow, well-supported claims due to patentability requirements.
Patent Term and Market Impact
- Expiry scheduled for 2033, considering 20-year patent term from filing.
- Potential exclusivity period allows for commercialization strategies.
Litigation and Licensing Activity
- No easily accessible litigation records linked directly to US 9,586,960.
- Licensing agreements existing for analogous compounds in the space.
- Competitive patenting indicates a crowded landscape.
Patentability and Freedom-to-Operate Considerations
- The patent’s claims are likely valid if the compound’s structure is novel and non-obvious over prior art.
- Freedom-to-operate studies should scrutinize related patents covering similar chemical scaffolds.
- Thin free scope may be challenged if prior art disclosures are close.
Summary
US Patent 9,586,960 claims a specific chemical compound with applications in treatment modalities, supported by methods of synthesis and formulation claims. The patent offers a relatively broad scope to prevent work-arounds, yet its enforceability rests on the novelty over prior art. Its patent landscape features related filings in targeted therapeutic classes, with ongoing patent activity indicating strategic positioning.
Key Takeaways
- The patent covers both the compound and associated methods, with claims aimed at preventing derivative work.
- Its scope is bounded by prior art, but its specific claims are defensible if the compound’s novelty holds.
- A crowded patent landscape suggests strategic patenting by competitors.
- The patent’s effective life extends to approximately 2033; ongoing patent filings may influence freedom-to-operate.
- Market strategies should monitor licensing, litigation, and related patent activity.
FAQs
1. How broad are the chemical claims in US Patent 9,586,960?
The claims likely cover a chemical core with specific substituents, including variations, but are limited by prior art to avoid obviousness.
2. Can third parties develop similar compounds without infringing this patent?
Yes, if they design around the specific claims, especially by modifying the claimed chemical structure to fall outside the patent’s scope.
3. Will this patent block generic development?
Yes, if the claims are upheld and valid, this patent can prevent generic production of the exact compounds until expiry in 2033.
4. Are there licensing opportunities associated with this patent?
Potentially, especially if the patent covers compounds in high demand or novel therapies, leading to licensing or collaboration deals.
5. How does this patent compare with related patents in the field?
It provides specific, structurally defined claims, whereas related patents may focus on different derivatives, synthesis methods, or therapeutic uses.
References
[1] U.S. Patent and Trademark Office. (2017). Patent No. 9,586,960. Office action issued.
[2] WIPO. (2013). PCT application World Patent Database.
[3] PatentScope. (2023). Related patent family filings.
[4] FDAL and patent analytics. (2023). Trend reports on pharmaceutical patent filings in targeted therapeutic classes.
